Lbel Supremacie Nx Jour Replenishing Treatment Daytime Face Spf 15 Normal To Dry Skin
Product Images NDC 43455-0005

3 FDA label images from Ventura International, Ltd · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lbel Supremacie Nx Jour Replenishing Treatment Daytime Face Spf 15 Normal To Dry Skin (NDC 43455-0005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ventura International, Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Supremacie Nx Jour (Supremacienxjour)

Supremacie Nx Jour (Supremacienxjour)
The packaging label for L'BEL SUPREMACIE NX JOUR replenishing daytime face cream SPF 15 for Normal to Dry Skin. The label presents the product name, its moisturizing benefits, and directions for use. It also includes skin care routine steps, warnings about sun exposure, and additional product features such as being hypoallergenic and dermatologically tested. The label states the product is made in France and the brand website www.lbel.com.*
FDA Label Image

Supremacie Nx Jour 50 G (Supremacienxjour50g)

Supremacie Nx Jour 50 G (Supremacienxjour50g)
Drug Facts text panels from LBEL SUPREMACIE NX JOUR Replenishing Treatment Daytime Face SPF 15 Normal To Dry Skin by Ventura International. The panels include active ingredients (Ensulizole, Homosalate, Octinoxate, Oxybenzone) with sunscreen purpose, directions for use, warnings about sun exposure and skin aging, inactive ingredients, and additional usage information.*
FDA Label Image

Supremacie Nx Jour 50 G A (Supremacienxjour50ga)

Supremacie Nx Jour 50 G A (Supremacienxjour50ga)
A product label panel titled 'USES AND WARNINGS' instructing to read the enclosed brochure. It lists active ingredients: Ensulizole 2.0%, Homosalate 2.0%, Octinoxate 7.5%, and Oxybenzone 4.0%. Distribution details for Ventura International Ltd in the US and Ventura Corporation Ltd in Puerto Rico are provided. The product is marked as made in France.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.